389 related articles for article (PubMed ID: 11014540)
1. Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker.
Harada K; Kurisu K; Tahara H; Tahara E; Ide T; Tahara E
J Neurosurg; 2000 Oct; 93(4):618-25. PubMed ID: 11014540
[TBL] [Abstract][Full Text] [Related]
2. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
[TBL] [Abstract][Full Text] [Related]
3. p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
Yoon KS; Lee MC; Kang SS; Kim JH; Jung S; Kim YJ; Lee JH; Ahn KY; Lee JS; Cheon JY
J Korean Med Sci; 2001 Aug; 16(4):481-8. PubMed ID: 11511795
[TBL] [Abstract][Full Text] [Related]
4. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
Pallini R; Pierconti F; Falchetti ML; D'Arcangelo D; Fernandez E; Maira G; D'Ambrosio E; Larocca LM
J Neurosurg; 2001 Jun; 94(6):961-71. PubMed ID: 11409526
[TBL] [Abstract][Full Text] [Related]
5. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
6. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
[TBL] [Abstract][Full Text] [Related]
7. In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, MIB1, and Topoisomerase IIalpha protein expression.
Miracco C; De Santi MM; Luzi P; Lalinga AV; Laurini L; De Nisi MC; Angeloni G; Brogi M; Cardone C; Carducci A; Arcuri F; Tosi P; Rubino G; Pirtoli L
Int J Oncol; 2003 Dec; 23(6):1529-35. PubMed ID: 14612923
[TBL] [Abstract][Full Text] [Related]
8. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas.
Lin PC; Lin SZ; Chen YL; Chang JS; Ho LI; Liu PY; Chang LF; Harn YC; Chen SP; Sun LY; Huang PC; Chein JT; Tsai CH; Chou CW; Harn HJ; Chiou TW
Ann Surg Oncol; 2011 Nov; 18(12):3514-27. PubMed ID: 21553143
[TBL] [Abstract][Full Text] [Related]
9. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
10. Regulation of telomerase and its hTERT messenger in colorectal cancer.
Boldrini L; Faviana P; Gisfredi S; Donati V; Zucconi Y; Ursino S; Simi P; Baldinotti F; Berti P; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G
Oncol Rep; 2004 Feb; 11(2):395-400. PubMed ID: 14719074
[TBL] [Abstract][Full Text] [Related]
11. In situ detection of telomerase catalytic subunit mRNA in glioblastoma multiforme.
Falchetti ML; Pallini R; D'Ambrosio E; Pierconti F; Martini M; Cimino-Reale G; Verna R; Maira G; Larocca LM
Int J Cancer; 2000 Dec; 88(6):895-901. PubMed ID: 11093811
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity and the expression of telomerase components in pituitary adenoma with malignant transformation.
Harada K; Arita K; Kurisu K; Tahara H
Surg Neurol; 2000 Mar; 53(3):267-74. PubMed ID: 10773260
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity in central nervous system malignant lymphoma.
Harada K; Kurisu K; Arita K; Sadatomo T; Tahara H; Tahara E; Ide T; Uozumi T
Cancer; 1999 Sep; 86(6):1050-5. PubMed ID: 10491533
[TBL] [Abstract][Full Text] [Related]
14. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.
Cabuy E; de Ridder L
Virchows Arch; 2001 Aug; 439(2):176-84. PubMed ID: 11561758
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.
Yu HP; Xu SQ; Lu WH; Li YY; Li F; Wang XL; Su YH
J Surg Oncol; 2004 May; 86(2):99-104. PubMed ID: 15112252
[TBL] [Abstract][Full Text] [Related]
17. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.
Jha P; Agarwal S; Pathak P; Srivastava A; Suri V; Sharma MC; Chosdol K; Srivastava T; Gupta D; Gupta A; Suri A; Sarkar C
Cancer Genet Cytogenet; 2010 Apr; 198(2):126-34. PubMed ID: 20362227
[TBL] [Abstract][Full Text] [Related]
18. Survivin in glioblastomas. Protein and messenger RNA expression and comparison with telomerase levels.
Kleinschmidt-DeMasters BK; Heinz D; McCarthy PJ; Bobak JB; Lillehei KO; Shroyer AL; Shroyer KR
Arch Pathol Lab Med; 2003 Jul; 127(7):826-33. PubMed ID: 12823036
[TBL] [Abstract][Full Text] [Related]
19. Low-level microsatellite instability phenotype in sporadic glioblastoma multiforme.
Martinez R; Schackert HK; Appelt H; Plaschke J; Baretton G; Schackert G
J Cancer Res Clin Oncol; 2005 Feb; 131(2):87-93. PubMed ID: 15672285
[TBL] [Abstract][Full Text] [Related]
20. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
